Imaging Controversies for Prostate Cancer - Phillip Koo

Presentation from the 2017 Annual LUGPA meeting in Chicago, IL

(Length of Presentation: 21 min)

Phillip Koo, MD discusses multiparametric prostate MRI (mpMRI) with local disease and a focus on PET/CT in advanced disease during his presentation of Imaging Controversies for Assessing Localized and Advanced PCa.  He reviews two surveys: Current Beliefs and Practice Patterns Among Urologists Regarding Prostate Magnetic Resonance Imaging and Magnetic Resonance-targeted Biopsy and A National Survey of Urologist’s Attitudes and Perception on Prostate MRI to uncover and drill down on the stage of perception vs reality of multi parametric MRI in current practice.

Dr. Koo compares C-11 Choline to 18F- Fluciclovine and the investigational clinical FALCON trial evaluating the impact of fluciclovine (18F) PET/CT imaging on the clinical management of men with biochemically recurrent prostate cancer as well as other targeted alpha therapies when determining an accurate imaging approach for patients with biochemically recurrent prostate cancer, when and how, to use them.

View More Session Coverage of LUGPA 2017

Biography:

Phillip J. Koo, MD 

Additional Related Content:

Accuracy of multiparametric MRI for prostate cancer detection: A meta-analysis - Abstract

Current Beliefs and Practice Patterns Among Urologists Regarding Prostate Magnetic Resonance Imaging and Magnetic Resonance-targeted Biopsy - Abstract

Blue Earth Diagnostics’ Initial Results from FALCON Trial Show 61% of Patients with Suspected Recurrent Prostate Cancer had Treatment Plan Changed Following Fluciclovine (18F) PET/CT Scan

Watch: New Hot Topic: Axumin™ (Fluciclovine F 18) Injection for PET Imaging of Recurrent Prostate Cancer - Phillip Koo

EVERYDAY UROLOGY: Axumin™ [Fluciclovine F18]: An Accurate Imaging Approach for Patients with Biochemically Recurrent Prostate Cancer-Full text article
 

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe